Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum to "Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis" [Cancer Treat. Rev. 110 (2022) 102463].
Corrie P, Meyer N, Berardi R, Guidoboni M, Schlueter M, Kolovos S, Macabeo B, Trouiller JB, Laramée P. Corrie P, et al. Among authors: trouiller jb. Cancer Treat Rev. 2023 Jan;112:102495. doi: 10.1016/j.ctrv.2022.102495. Epub 2022 Dec 8. Cancer Treat Rev. 2023. PMID: 36502614 Free article. No abstract available.
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis.
Corrie P, Meyer N, Berardi R, Guidoboni M, Schlueter M, Kolovos S, Macabeo B, Trouiller JB, Laramée P. Corrie P, et al. Among authors: trouiller jb. Cancer Treat Rev. 2022 Nov;110:102463. doi: 10.1016/j.ctrv.2022.102463. Epub 2022 Sep 6. Cancer Treat Rev. 2022. PMID: 36099854 Free article. Review.
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial.
Trouiller JB, Macabeo B, Poll A, Howard D, Buckland A, Sivignon M, Clay E, Malka D, Samalin E, Toumi M, Laramée P. Trouiller JB, et al. BMJ Open. 2022 Nov 21;12(11):e063700. doi: 10.1136/bmjopen-2022-063700. BMJ Open. 2022. PMID: 36410812 Free PMC article. Clinical Trial.
Cost-effectiveness and budget impact of cement augmentation for the fixation of unstable trochanteric fractures from a European perspective: Cost-effectiveness and budget impact of cement augmentation in Europe.
Radcliffe G, Trouiller JB, Battaglia S, Larrainzar-Garijo R. Radcliffe G, et al. Among authors: trouiller jb. Injury. 2024 Nov 10;55(12):111999. doi: 10.1016/j.injury.2024.111999. Online ahead of print. Injury. 2024. PMID: 39550804 Free article.
[How to measure real-world effectiveness?].
Launois R, Trouiller JB, Cabout E. Launois R, et al. Among authors: trouiller jb. Ann Pharm Fr. 2018 Nov;76(6):421-435. doi: 10.1016/j.pharma.2018.07.003. Epub 2018 Aug 10. Ann Pharm Fr. 2018. PMID: 30103940 Review. French.